Dafna Gladman
机构: Professor of Medicine
每年引用次数
引用次数
引用: 132,397
H-指数: 167
I10-指数 : 955
出版物: 2,522
Serologically active, clinically quiescent systemic lupus erythematosus--longterm followup.
O D Gladman , B A LeBlanc , M B Urowitz
The Journal of Rheumatology 21 ( 1) 174 -175
13
1994
Malakoplakia and immunosuppressive therapy. Reversal of clinical and leukocyte abnormalities after withdrawal of prednisone and azathioprine.
D. Gladman , W. J. Reynolds , C. Cardella , R. A. Bear
American Journal of Pathology 119 ( 1) 5 -11
46
1985
Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility
J.D. Reveille , O.T. McCann , H. Marzo-Ortega , J. Bruges-Armas
Faculty of Health; Institute of Health and Biomedical Innovation
903
2011
Erratum: A reliability study of SLEDAI: A disease activity index for SLE (J Rheumatol (1993) 20 (657-660))
C. Bombardier , D. Caron , C. Goldsmith , D. Gladman
The Journal of Rheumatology 20 ( 6)
1993
IN PATIENTS WITH PSORIATIC ARTHRITIS RECEIVING ADALIMUMAB, IMPROVEMENT IN PSORIASIS IS ASSOCIATED WITH LONG-TERM INHIBITION OF RADIOGRAPHIC PROGRESSION
E. Choy , C. Ritchlin , D. Gladman , P. J. Mease
Rheumatology 48
2009
Improvements in work productivity with up to 104 weeks of apremilast monotherapy: results from a phase 3b, randomized, controlled study in biologic-naive subjects with active psoriatic arthritis
P. Mease , P. Nash , L. Teng , X. Zhou
Scandinavian Journal of Rheumatology 47 34 -35
2018
LONG-TERM RADIOGRAPHIC OUTCOME IN PSORIATIC ARTHRITIS PATIENTS TREATED WITH GOLIMUMAB : 104 WEEK RESULTS FROM THE GO-REVEAL STUDY
G. Krueger , P. Mease , A. Beutler , N. Goldstein
39 ( 8) 1735 -1736
6
2012
Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: An international inception cohort study
J. G. Hanly , M. B. Urowitz , J. Sanchez-Guerrero , S. C. Bae
Arthritis & Rheumatism 56 ( 1) 265 -273
349
2007
Autoantibodies and neuropsychiatric events at the time of systemic lupus erythematosus diagnosis: results from an international inception cohort study.
J. G. Hanly , M. B. Urowitz , F. Siannis , V. Farewell
Arthritis & Rheumatism 58 ( 3) 843 -853
151
2008
Activité résiduelle de la maladie chez les patients atteints de rhumatisme psoriasique traités par sécukinumab et adalimumab ayant obtenu une rémission ou une faible activité de la maladie : étude de phase 3b, face-face, randomisée, en double aveugle
P. Goupille , P.J. Mease , D. Gladman , L. Coates
Revue du Rhumatisme 87
2020
Efficacité à long terme du filgotinib (FIL) dans le traitement du rhumatisme psoriasique : résultats à S52 de l’étude d’extension en ouvert EQUATOR2
C. Tasset , D. Gladman , L. Coates , F. Van den Bosch
Revue du Rhumatisme 87
2020
Effets à long terme sur le profil lipidique du filgotinib (FIL), inhibiteur spécifique de JAK1, dans le traitement du rhumatisme psoriasique : analyse des essais EQUATOR et EQUATOR2
C. Tasset , E. Husni , D. Gladman , P. Helliwell
Revue du Rhumatisme 87
2020
Caractérisation de la rémission chez des patients atteints de rhumatisme psoriasique traités par upadacitinib : analyse post hoc de deux essais de phase 3
P.J. Mease , A. Kavanaugh , D. Gladman , O. Fitzgerald
Revue du Rhumatisme 87
2020
SAT0305 MDA criteria for PSA show good correlation with physician and patient opinions and with proposed composite measures
L.C. Coates , O. Fitzgerald , D. Gladman , N. McHugh
Annals of the Rheumatic Diseases 71 575 -575
3
2013
193 Integrating health records and genetic signatures to enhance psoriatic arthritis risk assessment
M. Patrick , P.E. Stuart , K. Raja , J.E. Gudjonsson
Journal of Investigative Dermatology 137 ( 10)
2017
397 Fifty two-week efficacy and safety results from SPIRIT-P1: A Phase 3 study of ixekizumab in patients with active psoriatic arthritis
P. Mease , M. Okada , M. Kishimoto , C. Shuler
Journal of Investigative Dermatology 137 ( 10) S260
2
2017
Secukinumab in pregnancy: outcomes in psoriasis, psoriatic arthritis and ankylosing spondylitis from the global safety database.
R.B. Warren , K. Reich , R.G. Langley , B. Strober
British Journal of Dermatology 179 ( 5) 1205 -1207
35
2018
THU0006 Validation of Differential Methylation in Maternally Versus Paternally Transmitted Psoriatic Disease
V. Chandran , D. Gladman , P. Rahman , R.A. Pollock
Annals of the Rheumatic Diseases 74 195 -195
2015
Atherosclerotic vascular events in a multinational inception cohort of systemic lupus erythematosus
M. B. Urowitz , D. Gladman , D. Ibañez , S. C. Bae
Arthritis Care and Research 62 ( 6) 881 -887
141
2010
Effect of Certolizumab Pegol on Multiple Facets of Psoriatic Arthritis as Reported by Patients: 24‐Week Patient‐Reported Outcome Results of a Phase III, Multicenter Study
D. Gladman , R. Fleischmann , G. Coteur , F. Woltering
Arthritis Care and Research 66 ( 7) 1085 -1092
54
2014